News Quantified

AMGN – amgen inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts [Yahoo! Finance]

RFK Jr. May Want To Ban Prescription Drug Ads, But Can He? [Forbes]

Global Cancer Research Community Gathers to Share Breakthroughs at The Mark Foundation's 2025 Scientific Symposium [Yahoo! Finance]

UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE

Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now [Yahoo! Finance]

6.5%

BEAT

6.5%

BEAT

6.5%

BEAT

6.5%

BEAT

Wells Fargo & Company

Form ARS AMGEN INC For: Dec 31

Form 4 AMGEN INC For: Mar 17 Filed by: Santos Esteban

Form 4 AMGEN INC For: Mar 17 Filed by: REESE DAVID M

Form 4 AMGEN INC For: Mar 17 Filed by: Miller Derek

Form 4 AMGEN INC For: Mar 17 Filed by: Khosla Rachna

Top News Gainers

3/23 Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts 8.8%

8/8 Form 4 AMGEN INC For: Aug 07 Filed by: SUGAR RONALD D 6.2%

7/30 Amgen Reports Second Quarter 2019 Financial Results 6.1%

4/2 Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19 6.0%

8/26 UPDATE 2-Amgen to buy Celgene's psoriasis drug Otezla for $13.4 bln in cash [Reuters (UK)] 5.9%

4/7 Biotech Giant Amgen Entered The Coronavirus Arena — But Is It A Buy? [Investor's Business Daily] 5.9%

3/28 Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol 5.2%

8/12 Amgen, Inc. (NASDAQ: AMGN) had its "positive" rating re-affirmed by analysts at Wells Fargo & Co. They now have a $202.00 price target on the stock, up previously from $197.00. 5.0%

3/13 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at Cfra from a "hold" rating to a "buy" rating. 4.1%

3/26 Amgen, Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $250.00 to $240.00. They now have an "outperform" rating on the stock. 3.1%

Top News Decliners

3/14 Amgen, Inc. (NASDAQ: AMGN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -6.8%

3/7 Hedge Funds Have Never Been This Bullish On NVIDIA Corporation (NVDA) [Yahoo! Finance News] -5.8%

2/27 Amgen, Inc. (NASDAQ: AMGN) is now covered by analysts at Barclays PLC. They set an "equal weight" rating on the stock. -5.1%

3/24 Form 4 AMGEN INC For: Mar 20 Filed by: REESE DAVID M -4.6%

4/30 Form 8-K AMGEN INC For: Apr 30 -4.6%

1/30 Q4/2019 12/31/2019 EPS 3.640 ZacksConsensus 3.470 ActVsEst 0.170 - Beat -4.5%

2/25 Amgen Stock Is Forming A Flat Base — Is It Time To Bet On AMGN Stock? [Investor's Business Daily] -3.8%

8/2 Form 4 AMGEN INC For: Aug 01 Filed by: Santos Esteban -3.1%

3/10 Form 4 AMGEN INC For: Mar 09 Filed by: REESE DAVID M -2.8%

3/31 Form 8-K AMGEN INC For: Mar 31 -2.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day